The ␤2-integrin receptors (CD11a/ CD18, CD11b/CD18, and CD11c/CD18) are expressed on the surface of alveolar macrophages and are important for the phagocytic clearance of pathogens. In the present study, we demonstrate that surfactant protein D (SP-D) modulates surface expression of CD11b and CD11c, but not CD11a or CD18, on alveolar macrophages. While cell surface receptors were reduced, CD11b and CD11c mRNAs were increased by SP-D deficiency. CCSP-rtTA
mice, which conditionally express SP-D in the lung, were used to study the kinetics and reversibility of ␤2-integrin receptors in response to changes in alveolar SP-D. Surface CD11b and CD11c were reduced on the alveolar macrophages within 3 days of SP-D deficiency and were restored with 3 days for CD11b and 7 days for CD11c of repletion of SP-D. SP-D deficiency caused a loss of cellular CD11b and CD11c content, indicating that the decrease in total cell content of the receptors was related to degradation rather than to redistribution of the receptor within the macrophage. CD11b and CD11c staining colocalized with Lamp-1 during SP-D deficiency, supporting the concept that reduced macrophage receptor levels resulted from increased lysosomal trafficking. Hydroxychloroquine, a lysomotropic agent, prevented the reduction of cellular and surface CD11b and CD11c. SP-D regulates surface CD11b and CD11c levels on the alveolar macrophage by modulating receptor trafficking, providing a mechanism by which SP-D mediates phagocytic activity in the alveolar macrophage.
SURFACTANT PROTEIN D (SP-D) is a member of the collectin family of innate defense polypeptides that includes surfactant protein A (SP-A), mannose-binding lectin (MBL), conglutinin, and CL-43 (25, 28, 31) . Collectins form multimeric structures consisting of a collagenous NH 2 -terminal domain and a globular COOH-terminal carbohydrate-binding domain (33) that binds carbohydrate surfaces of many microorganisms, enhancing uptake and killing by phagocytic cells (36) . In addition to the integral role that SP-D plays in removal of microorganisms from the lung, surfactant proteins modulate phagocyte (9, 13, 29, 32, 37) and lymphocyte (5-7) function, thereby, underscoring the role of surfactant proteins in regulation of innate and adaptive immune function.
SP-D gene-inactivated mice (SP-D Ϫ/Ϫ
) are susceptible to various pulmonary pathogens. Phagocytosis of group B streptococcus (GBS), Haemophilus influenzae, influenza A virus, respiratory syncytial virus, and apoptotic cells by alveolar macrophages from the SP-D Ϫ/Ϫ mice is impaired (11, 23, 24, 26) . Phagocytosis of pathogens and apoptotic cells by alveolar macrophages is facilitated through pattern recognition receptors. Recent studies demonstrate that collectins modulate phagocytic receptor levels on alveolar macrophages. Specifically, SP-A enhances the surface expression of scavenger receptor A on the alveolar macrophage through a casein kinase-2-dependent pathway (22) . Similarly, both SP-A and SP-D increase cell surface levels of the mannose receptor on alveolar macrophages through a mechanism that does not involve new protein expression (4, 21) . SP-D deficiency causes matrix metalloproteinase-12 (MMP-12)-dependent shedding of CD14 from the alveolar macrophage cell surface (34) . Together these studies indicate that collectins are critical innate defense molecules that regulate alveolar macrophage function independently of, or in addition to, their direct opsonic effect. The ␤ 2 -integrins are heterodimeric receptors composed of one of three ␣-chains (CD11a, CD11b, or CD11c) and a common ␤-chain (CD18). ␤ 2 -Integrins are important mediators of binding and phagocytosis of microbial pathogens including GBS (1, 17) as well as apoptotic cells (18) . Functionally, the ␣-chain of the receptor confers specificity; CD11a functions only as an adhesion molecule, while CD11b and CD11c have overlapping functions for cell adhesion and phagocytosis. Cells of the monocyte/macrophage lineage express surface CD11a, CD11b, and CD11c; however, the number of each receptor changes as monocytes differentiate to macrophages. Alveolar macrophages express more CD11c and less CD11b than their monocytic precursors. Regardless of isoform specificity or cellular expression levels, the importance of ␤ 2 -integrins in phagocytic clearance is illustrated by the rare inherited immunodeficiency disease resulting from reduced leukocyte CD11/ CD18 expression that is associated with recurrent and often fatal bacterial infections (2) .
Although there is clear evidence that phagocytosis of GBS is impaired in SP-D Ϫ/Ϫ mice, mechanisms, other than pathogen opsonization, by which SP-D regulates innate host defense activities of alveolar macrophages, remain unclear. The present study was undertaken to identify mechanisms whereby SP-D regulates cell surface ␤ 2 -integrin expression and function.
MATERIALS AND METHODS

Animals. SP-D
Ϫ/Ϫ mice were generated by targeted gene inactivation as previously described (20 Peritoneal lavage. Mice were killed by administration of a lethal dose of pentobarbital sodium. The peritoneal cavity was lavaged with 5 ml of PBS. Cells in the peritoneal lavage fluid were recovered by centrifugation at 800 g and resuspended in FACS buffer.
Flow cytometric analysis. Isolated macrophages were resuspended in 200 l of FACS buffer and incubated with Fc block (rat anti-mouse CD16/32; BD Pharmingen, San Diego, CA) for 30 min at 4°C. Cells were incubated with phycoerythrin (PE)-conjugated anti-mouse CD11a, CD11b, CD11c, or CD18 (BD Pharmingen) for 1 h on ice and washed three times with FACS buffer. As controls, cells were assessed using primary isotype-and species-matched anti-mouse Igs. For some experiments, where total and extracellular expression of CD11b and CD11c was measured, macrophages were incubated with PE-conjugated anti-mouse CD11b or CD11c to determine surface expression, fixed and permeabilized using the Cytoperm Cytofix kit (BD Pharmingen), and one-half the population of cells was incubated with PE-conjugated anti-mouse CD11b or CD11c again to determine total cellular receptor levels. Cells were analyzed by single-color flow cytometry using a FACScan flow cytometer (BD Biosciences), and results were analyzed using CellQuest software on a Macintosh computer. Fluorescence data were collected using logarithmic amplification on 10,000 viable cells as determined by forward light scattering.
RNA isolation and real-time PCR analysis. Alveolar macrophages recovered by BAL were immediately lysed in 4 M guanidinium Restoration of SP-D expression for 3 days (ϪDox 3d, ϩDox 3d) was sufficient to increase alveolar macrophage CD11b to wildtype (ϩDox) levels. For CD11c, restoration of SP-D expression for 7 days (ϪDox 3d, ϩDox 7d) was necessary to restore surface expression to wildtype (ϩDox) levels. Flow cytometric analysis data are expressed as means Ϯ SE; n ϭ 6. *P Ͻ 0.05 compared with conditional CCSP-rtTA ϩ / (tetO)7-rSPD isothiocyanate, 0.5% laurylsarcosine, and 0.1 M ␤-mercaptoethanol in 25 mM sodium citrate buffer (GITC). Total RNA was isolated using the acidified guanidinium method (10), treated with DNase I (DNAfree; Ambion, Austin, TX), and reverse transcribed using a cDNA cycle kit (Invitrogen, Carlsbad, CA). PCR reaction mixes consisted of template, 0.5 M each primer, 2.5 mM MgCl 2, and 1ϫ DNA Master SYBR Green I (Roche Molecular Biochemicals, Indianapolis, IN) that contained Taq polymerase, dNTPs, SYBR Green dye, and buffer. Reaction conditions differed slightly, depending on the primers used, and generally were 95°C for 120 -150 s followed by 35-40 cycles of amplification (95°C for 6 -10 s, 59 -62°C for 10 -15 s, and 72°C for 15-25 s). Amplification product size and forward and reverse primer sequences, respectively, were as follows: L32 (257 bp), 5Ј-GTG-AAGCCCAAGATCGTC-3Ј, 5Ј-AGCAATCTCAGCACAGTAAG-3Ј; CD11a (190 bp), 5Ј-CTCCAGGAGGACAACTCAGC-3Ј, 5Ј-CTA-GTGTGGGCATGTTGTGG-3Ј; CD11b (195 bp), 5Ј-GCAGTCATCT-TGAGGAACCGTGTC-3Ј, 5Ј-GTTGGTATTGCCATCAGCGTCC-3Ј; and CD11c (181 bp), 5Ј-ATGTTGGAGGAAGCAAATGG-3Ј, 5Ј-CCT-GGGAATCCTATTGCAGA-3Ј. Measurement of amplified product was made for 6 s every cycle at a temperature above that of the melting temperature of possible nonspecific products (e.g., primerdimers) and 1-2°C below the melting temperature of the specific product. Melt curve analyses were performed after every run to ensure that a single amplified product was produced. Relative quantitation was obtained by measuring the cycle at which the greatest accumulation of product occurred (cycle threshold, Ct) and plotting that against the cycle thresholds of a dilution series of positive control samples. Only experiments in which the regression analysis of the dilution series gave an r-squared value Ն0.985 were used to determine quantitation.
Hydroxychloroquine treatment of mice. CCSP-rtTA ϩ /(tetO)7-rSPD ϩ /SP-D Ϫ/Ϫ mice were treated with the lysomotropic drug hydroxychloroquine at a dose of 10 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 for 4 days before and 3 days following removal of doxycycline from the diet of the CCSP-rtTA ϩ /(tetO)7-rSPD ϩ /SP-D Ϫ/Ϫ mice. The dose of 10 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 was chosen based on its efficacy in ameliorating idiopathic pulmonary fibrosis without deleterious side effects to the patients (14) .
Fluorescence microscopy. Alveolar macrophages were plated on poly-D-lysine-treated coverslips and allowed to adhere for 2 h and then gently washed two times with PBS to remove nonadherent cells. Cells were fixed with 4% paraformaldehyde in PBS, permeabilized with 0.1% Triton X-100, and stained with an FITC-conjugated monoclonal antibody against Lamp-1 (CD107a) and a PE-conjugated monoclonal antibody against CD11b or CD11c (all from BD Pharmingen) for 2 h at 37°C. Cells were washed three times with PBS and one time with double distilled H20 and mounted on slides with Vectashield mounting medium(Vector Laboratories, Burlingame, CA). Wide-field fluorescent images were acquired by using a Zeiss Axioplan 2 microscope equipped with an ApoTome system for optical sectioning and an AxioCam HRm camera (Carl Zeiss Microimaging, Thornwood, NY).
Statistical methods. Results were compared using ANOVA and Student's t-test. Findings were considered statistically significant at probability levels Ͻ0.05. Results are presented as means Ϯ SE. 
RESULTS
Reduced ␤ 2 -integrins on alveolar macrophages from SP-D
Ϫ/Ϫ mice. Surface expression of CD11a, CD11b, CD11c, and CD18 was assessed by flow cytometric analysis on alveolar macrophages from SP-D Ϫ/Ϫ and SP-D ϩ/ϩ mice. Previous studies demonstrated that alveolar macrophages from SP-D Ϫ/Ϫ mice exhibit altered morphology (20, 35) , impaired phagocytosis (26) , and reduced levels of the pattern recognition receptor, CD14 (34) . Cell surface CD11b and CD11c were decreased by 58 and 54%, respectively, on alveolar macrophages from SP-D Ϫ/Ϫ compared with SP-D ϩ/ϩ mice (Fig. 1) . In contrast, the cell surface expression of CD11a on the alveolar macrophage was not influenced by the lack of SP-D (Fig. 1) . (Fig. 3) . Surface expression of CD11b was restored by reexpression of SP-D for 3 days (Fig. 3) . Expression of SP-D for 7 days was required to restore surface CD11c expression to normal levels (Fig. 3) .
Rapid regulation of alveolar macrophage CD11b and CD11c mRNA during SP-D depletion. Real-time PCR analysis was used to measure the mRNA levels of alveolar macrophage CD11b and CD11c during SP-D depletion. Alveolar macrophage CD11b and CD11c mRNA levels were increased 3 days following the loss of SP-D (Fig. 4) .
Increased lysosomal localization of CD11b and CD11c following the loss of SP-D. Flow cytometric analysis was used to assess cell surface and total cellular levels of CD11b and CD11c on alveolar macrophages during depletion of SP-D. Loss of SP-D resulted in reduced total cellular and cell surface levels of alveolar macrophage CD11b and CD11c (Fig. 5) . SP-D did not influence intracellular levels of CD11b or CD11c in alveolar macrophages (Fig. 5) . These results suggest that loss of SP-D does not promote redistribution of CD11b and CD11c from the cell surface to an intracellular storage vesicle but caused their degradation.
Lysosomal localization of CD11b and CD11c was assessed by colocalizing CD11b and CD11c with the lysosomal marker Lamp-1. Increased colocalization of both CD11b and CD11c with Lamp-1 was observed in alveolar macrophages from CCSP-rtTA ϩ /(tetO) 7 -rSPD ϩ /SP-D Ϫ/Ϫ mice 3 days after loss of SP-D (Fig. 6) . Together, the data suggest that SP-D deficiency causes lysosomal trafficking and degradation of CD11b and CD11c.
Hydroxychloroquine inhibits SP-D-dependent loss of alveolar macrophage CD11b and CD11c. CCSP-rtTA ϩ /(tetO) 7 rSPD ϩ /SP-D Ϫ/Ϫ mice were treated with the lysomotropic agent hydroxychloroquine to determine whether the reduction of CD11b and CD11c caused by SP-D depletion was mediated by lysosomal degradation. Flow cytometric analysis was used to assess cell surface and total cellular expression of CD11b and CD11c on alveolar macrophages from mice where SP-D was depleted for 3 days. Hydroxychloroquine treatment increased total, extracellular, and intracellular levels of SP-Ddeficient alveolar macrophage CD11b and CD11c (Fig. 7) , supporting the concept that SP-D deficiency causes increased lysosomal trafficking and degradation of alveolar macrophage CD11b and CD11c. Results from the current study show that alveolar macrophages from SP-D Ϫ/Ϫ mice exhibit reduced levels of CD11b and CD11c; however, the macrophages have a relative surface expression pattern of CD11c Ͼ CD11a Ͼ CD11b, a finding consistent with ␤ 2 -integrin surface expression on normal alveolar macrophages.
Alveolar macrophage surface expression of CD11b and CD11c was significantly reduced 3 days after the conditional loss of SP-D, and this was readily reversible. The observation that the receptor changes were reversible is consistent with previous observations in CCSP-rtTA ϩ /(tetO) 7 -rSPD ϩ /SP-D Ϫ/Ϫ mice where abnormalities in alveolar macrophage morphology and lipid content were also readily reversed by restoration of SP-D in the adult mice (38) . It is also important to note that it is unlikely that the changes to ␤ 2 -integrin surface expression observed in these studies are due to the abnormalities in surfactant phospholipid pools observed previously by Ikegami et al. (19) , since phospholipid changes were not observed until 2 wk after the loss of SP-D.
In addition to cell surface changes, migration of monocytes from the blood to the lung promotes cellular differentiation to alveolar macrophages by initiating a specific gene transcription pattern that results in a cell type-specific cell surface receptor profile. During the monocyte-to-macrophage differentiation process, CD11b mRNA expression is repressed by ZBP-89 binding to response elements in the promoter of the CD11b gene (30) . Likewise, CD11c mRNA expression is regulated by transcription factors binding to activator protein-1 and C/EBP elements within the promoter region during the differentiation from monocyte to macrophage (12) . Given the changes observed in receptor expression on the alveolar macrophage cell surface, we sought to determine whether the reduction in CD11b and CD11c could be explained by decreased mRNA expression. The results from this study indicate that transcriptional repression cannot account for the observed decreases in CD11b and CD11c receptor levels, as mRNA levels for both genes were elevated with the loss of SP-D from the lung.
Cell surface receptors are routinely endocytosed and then enter a complex sorting pathway where they may be stored, destroyed, or recycled back to the cell surface (27) . On the basis of the fact that neutrophil CD11b is stored in granules and released to the cell surface on stimulation, our initial hypothesis was that loss of SP-D promotes the intracellular localization of CD11b and CD11c in the alveolar macrophage. The flow cytometric analysis data from this study do not support this concept and are consistent with reports that macrophages do not store CD11b for release (3) . Instead, the current study suggests that SP-D prevents CD11b and CD11c from being targeted for lysosomal degradation. The current study also shows that SP-D influences cell surface expression of CD11b and CD11c, two functionally similar receptors, but not CD11a. The differential regulation is likely due to differences in receptor substrate specificity and also due to trafficking differences conferred by the cytoplasmic tail of the ␣-chain of the receptor (8) . The collectins SP-A and MBL bind the ␣ 2 ␤ 1 -integrin receptor on the I-domain of the ␣-chain (15) . Ligand binding to the I-domain of the integrin ␣-chain correlates with a higher-affinity form of the receptor and promotes clustering of laterally associated integrins (16) . It is presently unclear what effect ␣-chain I-domain binding has on ␤ 2 -integrin receptor trafficking. Interestingly, SP-D Ϫ/Ϫ mice also have reduced levels of SP-A (19, 20) . We propose that the pulmonary collectins SP-A and SP-D directly or indirectly modulate CD11b and CD11c receptor affinity and thereby prevent receptor degradation.
In summary, SP-D is an important regulator of microbial clearance and inflammatory processes that are essential for host defense and pulmonary homeostasis. The current study demonstrates that SP-D regulates ␤ 2 -integrin receptor recycling and degradation.
